Ilene Rothman, MD

PrintE-mail
Assistant Professor
Department of Dermatology
Roswell Park Cancer Institute
Chief of Pediatric Dermatology
Women and Children’s Hospital of Buffalo

Profile

Areas of Expertise: 
Atopic dermatitis
Basal cell carcinoma
Hemangiomas
Melanoma
Mosaic skin conditions
Precancerous skin conditions
Squamous cell carcinoma
Vascular anomalies

Research

Research Interests: 
Impact of an educational program on the quality of life of children with atopic dermatitis and their families

Background Information

Education and Training: 
MD - Temple University School of Medicine, Philadelphia, PA
BA - John Hopkins University, Baltimore, MD
Residency: 
Rhode Island Hospital (Pediatrics), Brown University, Providence, RI
School of Medicine and Biomedical Sciences (Dermatology), State University of New York at Buffalo
Board Certification: 
Pediatrics, American Board of Pediatrics
Dermatology, American Board of Dermatology
Pediatric Dermatology, American Board of Dermatology

Publications

Publications: 
  • Esler-Brauer L, Rothman I. Tender nodules on the palms and soles: palmoplantar eccrine hidradenitis. Archives of dermatology 2007; 143(9):1201-1206
  • Nazareth MR, Bunimovich O, Rothman IL. Trichomegaly in a 3-year-old girl with alopecia areata. Pediatric dermatology 2009; 26(2):188-193
  • Nornhold E, Li A, Rothman IL, Lakshminrusimha S, Helm TN. Vesiculopustular eruption associated with transient myeloproliferative disorder. Cutis 2009; 83(5):234-236
  • Powell JG, Ramsdell A, Rothman IL. Eosinophilic cellulitis (Wells syndrome) in a pediatric patient: a case report and review of the literature. Cutis 2012; 89(4):191-194

Cancer Can't Win

More patients are being diagnosed with cancer every day.

Here at Roswell Park Cancer Institute, we must continue to do what we do best – to understand, prevent and cure cancer. Because if we don’t, cancer wins. And Cancer Can’t Win.

  • With more than 3,000 scientific, academic and medical minds – Cancer Can’t Win.
  • When we are leading an advanced genetic program and creating next generation cancer vaccines to prevent it – Cancer Can’t Win.
  • When we are starting 13 new companies to advance our discoveries and share them with the world – Cancer Can’t Win.

Learn more about why Cancer Can’t Win

close